Man Group’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Buy
94,088
+16,184
+21% +$160K ﹤0.01% 1833
2026
Q1
$717K Buy
77,904
+14,510
+23% +$121K ﹤0.01% 1949
2025
Q4
$471K Buy
63,394
+7,397
+13% +$50.7K ﹤0.01% 1906
2025
Q3
$380K Sell
55,997
-26,501
-32% -$179K ﹤0.01% 1934
2025
Q2
$570K Buy
82,498
+18,025
+28% +$122K ﹤0.01% 1787
2025
Q1
$469K Buy
64,473
+52,653
+445% +$413K ﹤0.01% 1817
2024
Q4
$94.8K Buy
+11,820
New +$103K ﹤0.01% 1931
2023
Q1
Sell
-17,127
Closed -$149K 1862
2022
Q4
$129K Buy
+17,127
New +$116K ﹤0.01% 1862

Other funds holding VMD

Man Group's VMD Position: Q2 2026 in Review

Man Group increased its Viemed Healthcare (VMD) stake by 21% in Q2 2026, buying an estimated $160K and bringing the position to 94,088 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

Man Group first reported a position in VMD in Q4 2022 and has held it in 8 quarters since. 167 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Man Group held 94,088 shares of Viemed Healthcare worth $1.07M as of Q2 2026.
  • Man Group bought 16,184 Viemed Healthcare shares in Q2 2026, an estimated $160K.
  • Viemed Healthcare made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1833 holding.
  • Man Group first reported a position in Viemed Healthcare in Q4 2022 and has held it in 8 quarters since.
  • 167 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.